User's blog

Author: Paramraj Singh Sondhi

  • Caregiver Resources

    Caregivers often play a central role in helping patients make decisions about clinical trials. DecenTrialz equips you with caregiver-specific materials to share during family consultations or discharge planning.

    What You Can Provide

    • Caregiver-focused FAQs explaining their role in the trial process
    • Consent support guides to help caregivers assist patients in understanding informed consent forms
    • Checklists and tips for trial visits, follow-up, and remote participation
    • Crisis planning and safety information for trials involving sensitive populations

    All caregiver resources are available in downloadable formats and designed to support shared decision-making.

    Key Note: When a caregiver is acting on behalf of a minor or adult with diminished capacity, always ensure they have proper legal authority and documentation. Refer such cases to the research site team.

  • Visual Explainers for Patients

    Visual tools can significantly improve patient understanding, especially when explaining complex research topics like trial phases, randomization, or pre-screening. DecenTrialz provides a set of medically reviewed, IRB-compliant visual explainers you can use during patient education sessions.

    What’s Included

    • Infographics about how clinical trials work
    • Step-by-step visuals showing what to expect before, during, and after trial participation
    • Comparisons between standard care and trial participation
    • Mobile-friendly formats for easier sharing via SMS or email

    These visual explainers are designed for all literacy levels and available in multiple languages to support diverse communities.

    Key Note: Visuals are especially helpful for elderly patients, non-native English speakers, and those with low health literacy. Consider using them alongside verbal counseling.

  • Shareable FAQs

    To support conversations about clinical research, DecenTrialz offers printable and shareable FAQs designed for patient education. These can be used during appointments, handed out at discharge, or shared digitally.

    Topics Covered

    • What are clinical trials?
    • Why would someone join a trial?
    • Are trials safe?
    • What is informed consent?
    • What happens if I change my mind?

    Formats Available

    • PDF handouts (print-ready)
    • Digital summaries for email/text
    • Translated versions in multiple languages

    Key Note: All materials are written at a 6th–8th grade reading level and reviewed by ethics advisors for clarity, cultural sensitivity, and compliance.

  • Tracking Referral Status

    Once a patient is referred through the DecenTrialz HCP portal, providers can track the progress of that referral in real time. This transparency allows you to remain informed about your patient’s research journey while respecting their autonomy.

    What You Can See

    • Pre-Screening Outcome: Whether the patient passed initial eligibility filters.
    • Contact Attempts: If DecenTrialz has reached out, and whether the patient responded.
    • Site Referral Status: If the patient has been referred to a study site.
    • Final Disposition: Whether the patient chose to proceed or declined participation.

    How It Works

    • Log into your HCP dashboard.
    • Navigate to the “Referrals” tab.
    • Click any patient entry to see live status updates and referral notes.

    Key Note: To maintain privacy and trial integrity, sensitive details (e.g., investigational drug names, trial arms, or specific medical results from the study) are not shared back to the referring HCP unless the patient has given explicit consent.

  • Patient Privacy and HIPAA

    DecenTrialz is fully compliant with the Health Insurance Portability and Accountability Act (HIPAA), ensuring that all patient data shared during referral or pre-screening is handled with the highest standard of privacy and security.

    How We Protect Your Patient’s Information

    • De-identified Data by Default: Unless specifically required and consented to, DecenTrialz only shares de-identified data with research partners during pre-screening.
    • Encrypted Transmission: All data entered through the HCP referral dashboard is encrypted in transit and at rest using industry-standard protocols.
    • Role-based Access Control: Only authorized personnel at approved research sites can access participant information, and even then, only the minimum necessary.
    • Audit Trails: Every access to participant data is logged for regulatory compliance and internal auditing.

    Key Note: HCPs should avoid sending trial-related info via email, WhatsApp, or EHR notes. Use the DecenTrialz referral portal to maintain HIPAA alignment.

  • Ensuring Consent Before Referral

    Referrals must be based on a patient’s understanding and agreement. Even for pre-screening, DecenTrialz requires patient awareness that their information may be shared with a research site.

    Provider Best Practices

    • Never refer without discussion. Patients must know what they’re being referred to and why.
    • Use consent-ready language. For example: “Would you be open to learning about a research study that may be relevant to your condition?”
    • Document patient agreement. Make a note in your EHR or on the DecenTrialz platform that the patient has given verbal consent for referral.

    Key Note: Pre-screening on DecenTrialz is non-binding. Patients can withdraw their interest at any time, and referral alone does not enroll them in a study.

  • How to Refer Patients to DecenTrialz

    • Step 1: Identify eligibility
      Use the trial filters or AI-matching tool on DecenTrialz to see if a patient fits the general inclusion criteria of an active trial.
    • Step 2: Discuss with patient
      Before referral, have an open discussion with the patient (see Talking to Patients About Research) and confirm their interest.
    • Step 3: Submit pre-screening
      Log in to your HCP portal on DecenTrialz, Log in to your secure HCP portal, fill in the minimum necessary referral details as prompted, and submit a referral request. You can track progress from your dashboard.
    • Step 4: Receive updates
      You’ll be notified when the patient is contacted, pre-screened, or enrolled (if applicable).

    Key Note: DecenTrialz never bypasses the physician-patient relationship. Our platform supports informed exploration, you remain a key part of your patient’s care journey.

  • How Trials Protect Patient Safety

    Patient safety is the cornerstone of ethical clinical research. All approved clinical trials must follow strict guidelines to ensure participants are not exposed to unnecessary risk. As a healthcare provider, understanding these safeguards helps you confidently refer patients and answer their questions.

    Key Safety Protections in Clinical Trials

    • IRB/Ethics Committee Review: All trial protocols are reviewed by an Institutional Review Board (IRB) or Ethics Committee before recruitment begins. These boards ensure that risks are minimized, benefits are reasonable, and informed consent is properly structured.
    • Data Monitoring Committees (DMCs): Independent committees may oversee ongoing trials to monitor safety data, flag adverse events, or recommend stopping the study if harm is observed.
    • Regulatory Compliance: Trials must follow Good Clinical Practice (GCP) guidelines and are subject to inspections by regulators like the U.S. FDA, EMA, or CDSCO.
    • Ongoing Reporting and Audits: Investigators are required to report serious adverse events (SAEs) in real-time to sponsors, regulators, and IRBs.

    Key Note: Providers should ask if a study is IRB-approved, registered, and has appropriate oversight mechanisms in place before referring patients.

  • Talking to Patients About Research

    Discussing clinical trial participation with patients requires clarity, empathy, and ethical responsibility. As a healthcare provider, your recommendation carries significant weight in how patients perceive research. A well-informed, non-coercive conversation can help them explore opportunities that align with their care goals.

    How to Initiate the Conversation

    • Begin with relevance: Explain why you’re suggesting a clinical trial, e.g., “There’s a research opportunity studying new treatments for your condition.”
    • Use plain language: Avoid technical jargon. Clearly describe what the trial is studying, how it differs from routine care, and what it may involve.
    • Normalize participation: Let patients know that research is a voluntary and respected part of healthcare, and many others explore these options.
    • Clarify your role: Emphasize that your support continues whether or not they choose to participate.

    What to Cover in the Discussion

    • What the study is about
    • What participation may involve (e.g., visits, procedures, risks, time commitment)
    • Their rights (e.g., informed consent, right to withdraw)
    • What is not guaranteed (e.g., benefit or access to treatment post-trial)
    • How privacy will be protected

    Key Do’s and Don’ts

    DoDon’t
    Explain risks and benefits clearlyPromise outcomes or benefits
    Encourage questionsPressure the patient to decide
    Offer written informationSkip informed consent basics

    Key Note: Always give patients time to think, discuss with family, or speak with the research team. Their decision should be voluntary and fully informed. If you’re unsure how to explain a specific trial, DecenTrialz provides ready-made explainer materials to support your conversations.

  • What Are Clinical Trials? (For Providers)

    Clinical trials are research studies that evaluate the safety, effectiveness, and outcomes of medical interventions, including drugs, devices, diagnostics, and behavioral strategies. These trials are essential for generating high-quality evidence that guides clinical decision-making, regulatory approvals, and standard-of-care updates.

    For healthcare providers, understanding clinical trials is critical, not only for advancing medicine but also for supporting informed patient care. Referring patients to trials gives them access to potentially beneficial treatments while contributing to science that benefits future populations.

    Key Components of Clinical Trials

    • Protocol-driven: Every trial follows a predefined plan outlining eligibility, procedures, safety measures, and endpoints.
    • Phased Research: Most trials follow phased development (from early safety to large-scale efficacy).
    • Regulatory Oversight: Trials are reviewed and approved by Institutional Review Boards (IRBs) or Ethics Committees, and may be registered with national authorities like the FDA (USA) or CDSCO (India).
    • Participant-Centric Design: Modern trials emphasize risk minimization, informed consent, data privacy, and real-world relevance.

    Key Note: As an HCP, you play a vital role in bridging clinical care and research. Your understanding and communication can help patients make informed decisions about participating in trials aligned with their goals and conditions.